Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
38.68
-0.04 (-0.10%)
Streaming Delayed Price
Updated: 11:41 AM EDT, Mar 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,166,155
Open
38.73
Bid (Size)
38.68 (500)
Ask (Size)
38.69 (800)
Prev. Close
38.72
Today's Range
38.56 - 38.99
52wk Range
35.85 - 82.57
Shares Outstanding
N/A
Dividend Yield
3.02%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
March 10, 2026
From
Pomerantz LLP
Via
GlobeNewswire
The Great Biotech Divide: Vertex Soars on Multi-Franchise Breakthroughs as Novo Nordisk Stumbles in the Weight-Loss War
March 10, 2026
The healthcare sector has entered a period of sharp divergence in early 2026, creating a "bifurcated market" where clinical innovation is rewarding a select few while punishing former industry...
Via
MarketMinute
Performance
YTD
-26.2%
-26.2%
1 Month
-21.6%
-21.6%
3 Month
-16.6%
-16.6%
6 Month
-28.8%
-28.8%
1 Year
-51.0%
-51.0%
More News
Read More
Novo Nordisk Sentiment Shifts as REDEFINE 4 Trial Results Trigger 16% Stock Plunge
March 10, 2026
Via
MarketMinute
Topics
Government
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal
↗
March 10, 2026
Via
MarketBeat
Viking CEO Sees Its Obesity Drug Beating Novo's Wegovy In Weight Loss
↗
March 10, 2026
Via
Stocktwits
2 Healthcare Stocks That Are Too Cheap to Ignore
↗
March 10, 2026
Via
The Motley Fool
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
March 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Lawsuit
Disrupting the Pharmacy: A Deep-Dive into Hims & Hers Health (HIMS) in 2026
March 10, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock
↗
March 10, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock Rockets To Best Day Ever After Novo Nordisk Pact — Wall Street Upgrades Roll In As Shorts Lose $546M In One Day
↗
March 10, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
↗
March 09, 2026
Via
The Motley Fool
Topics
Lawsuit
Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock
↗
March 09, 2026
Via
The Motley Fool
Hims & Hers Stock Pops 40%: Everything You Need to Know
↗
March 09, 2026
Via
The Motley Fool
Topics
Lawsuit
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy
↗
March 09, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock Could Rally Up To 60% This Week? Fund Manager Says He Wouldn’t Be ‘Surprised’ As Novo Nordisk Patch-Up Buzz Grows
↗
March 09, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Better Weight Loss Stock: Novo Nordisk Vs. Amgen
↗
March 08, 2026
Via
The Motley Fool
2 Underrated Weight Loss Stocks to Buy Now
↗
March 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
Can This Next-Gen Obesity Drug Save Novo Nordisk?
↗
March 07, 2026
Via
The Motley Fool
Novo Nordisk To Partner With Hims & Hers To Sell Weight-Loss Drugs: Report
↗
March 07, 2026
Via
Stocktwits
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market?
↗
March 06, 2026
Via
The Motley Fool
Novo Nordisk's Obesity Setback: What Kagrama's Miss vs. Zepbound Means for Investors
↗
March 05, 2026
Via
The Motley Fool
The Compounding Cliff: Hims & Hers Faces Reckoning as FDA and Big Pharma Close GLP-1 Loopholes
March 04, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Lawsuit
Novo Nordisk’s Brief Rebound Fizzles: Apple-Style Justin Long Ozempic Ad Draws FDA Warning Again
↗
March 04, 2026
Via
Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
March 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
↗
March 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 38.68
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 03/11/26 11:41 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today